Literature DB >> 18766458

Protective effects of immunophilin ligands on testicular torsion/detorsion damage in rats.

Behtash Ghazi Nezami1, Sina Rahimpour, Taha Gholipour, Seyedmehdi Payabvash, Reza Rahimian, Seyed Mohammad Tavangar, Seyed Hassan Emami-Razavi, Ahmad Reza Dehpour.   

Abstract

OBJECTIVES: The purpose was to investigate the role of immunophilin ligands in ischemia/reperfusion (I/R)-induced germ cell apoptosis in the rat.
MATERIALS AND METHODS: Sprague-Dawley rats were divided into five groups with ten animals in each. In animals undergoing torsion/detorsion, right testes were rotated 720 degrees for 1 h. A baseline group was for basal normal values. The sham-operated group served as a control group. The TD group underwent torsion/detorsion surgery alone; the cyclosporine-A group (TD-CsA) received intravenous cyclosporine injection (5 mg/kg) at the time of detorsion, and the FK-506 group (TD-FK) received intravenous FK-506 (3.5 mg/kg) at the time of detorsion. For measurement of lipid peroxidation and antioxidant enzyme activities, the right testes of five animals in each group were excised after 4-h reperfusion. Germ cell apoptosis indices were determined 24 h following detorsion in the right testes of the remaining five animals in each group.
RESULTS: Malondialdehyde (MDA) levels in the TD group were significantly higher compared to control and baseline groups. Moreover, testicular MDA values in TD-CsA and TD-FK groups were significantly lower than in TD. There were also significant decreases in catalase and superxide dismutase activities in the TD group compared to control and baseline groups. These values in TD-CsA and TD-FK groups were significantly higher than in TD. The mean germ cell apoptosis scores were significantly higher in TD animals compared to control and baseline groups; however, CsA and FK-506 treatment significantly reduced the apoptosis compared with the TD group.
CONCLUSION: We have shown that administration of immunophilin ligands in testicular torsion decreases ischemia/reperfusion (I/R) cellular damage. The results of biochemical studies suggest that reduction of oxidative stress along with attenuated neutrophil accumulation by immunophilin ligands may have a major role in their cytoprotective effects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18766458     DOI: 10.1007/s11255-008-9453-5

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  37 in total

Review 1.  Calcineurin. Structure, function, and inhibition.

Authors:  C S Hemenway; J Heitman
Journal:  Cell Biochem Biophys       Date:  1999       Impact factor: 2.194

2.  Inhibition of leukocyte chemotaxis by immunosuppressive agents. Specific inhibition of lymphocyte chemotaxis by cyclosporine.

Authors:  D H Adams; L F Wang; J M Neuberger; E Elias
Journal:  Transplantation       Date:  1990-11       Impact factor: 4.939

3.  Determination of superoxide dismutase activity by purely chemical system based on NAD(P)H oxidation.

Authors:  F Paoletti; A Mocali
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

Review 4.  Immunophilins in protein folding and immunosuppression.

Authors:  D A Fruman; S J Burakoff; B E Bierer
Journal:  FASEB J       Date:  1994-04-01       Impact factor: 5.191

5.  The continuing conundrum of testicular torsion.

Authors:  R C Williamson
Journal:  Br J Surg       Date:  1985-07       Impact factor: 6.939

Review 6.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.

Authors:  M Baggiolini; A Walz; S L Kunkel
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

7.  Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine.

Authors:  S Suzuki; L H Toledo-Pereyra; F J Rodriguez; D Cejalvo
Journal:  Transplantation       Date:  1993-06       Impact factor: 4.939

8.  Purification and characterization of cytokine-induced neutrophil chemoattractant produced by epithelioid cell line of normal rat kidney (NRK-52E cell).

Authors:  K Watanabe; S Kinoshita; H Nakagawa
Journal:  Biochem Biophys Res Commun       Date:  1989-06-30       Impact factor: 3.575

9.  Pentoxifylline improves blood flow to both testes in testicular torsion.

Authors:  Cağri Savaş; Hüseyin Dindar; Tülin Aras; Selçuk Yücesan
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

10.  Protective effects of sildenafil administration on testicular torsion/detorsion damage in rats.

Authors:  Azadeh Beheshtian; Amirali Hassanzadeh Salmasi; Seyedmehdi Payabvash; Saman Kiumehr; Behtash Ghazinezami; Sina Rahimpour; Seyed Mohammad Tavangar; Ahmad Reza Dehpour
Journal:  World J Urol       Date:  2008-02-12       Impact factor: 4.226

View more
  4 in total

Review 1.  Contemporary review of testicular torsion: new concepts, emerging technologies and potential therapeutics.

Authors:  Daniel G DaJusta; Candace F Granberg; Carlos Villanueva; Linda A Baker
Journal:  J Pediatr Urol       Date:  2012-10-06       Impact factor: 1.830

2.  Beneficial effects of taurine and carnosine in experimental ischemia/reperfusion injury in testis.

Authors:  Latif Abbasoğlu; Esra Betül Kalaz; Merva Soluk-Tekkeşin; Vakur Olgaç; Semra Doğru-Abbasoğlu; Müjdat Uysal
Journal:  Pediatr Surg Int       Date:  2012-09-09       Impact factor: 1.827

Review 3.  The hypoxic testicle: physiology and pathophysiology.

Authors:  Juan G Reyes; Jorge G Farias; Sebastián Henríquez-Olavarrieta; Eva Madrid; Mario Parraga; Andrea B Zepeda; Ricardo D Moreno
Journal:  Oxid Med Cell Longev       Date:  2012-09-27       Impact factor: 6.543

4.  Beneficial effects of Cyclosporine A in combination with Nortriptyline on germ cell-specific apoptosis, oxidative stress and epididymal sperm qualities following testicular ischemia/reperfusion in rats: a comparative study.

Authors:  Iraj Yazdani; Raheleh Majdani; Morteza Ghasemnejad-Berenji; Ahmad Reza Dehpour
Journal:  BMC Pharmacol Toxicol       Date:  2022-08-05       Impact factor: 2.605

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.